Matches in Wikidata for { <http://www.wikidata.org/entity/Q65346681> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q65346681 description "clinical trial" @default.
- Q65346681 description "ensayu clínicu" @default.
- Q65346681 description "klinisch onderzoek" @default.
- Q65346681 description "клінічне випробування" @default.
- Q65346681 description "կլինիկական փորձարկում" @default.
- Q65346681 name "Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 name "Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 type Item @default.
- Q65346681 label "Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 label "Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 prefLabel "Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 prefLabel "Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 P1050 Q65346681-06B20F48-EA1B-4B29-8A2D-A76A22454BFB @default.
- Q65346681 P1132 Q65346681-548DF0FC-0024-4ED1-9AEF-2A7CDFCFBCF2 @default.
- Q65346681 P1476 Q65346681-BBF0BE0B-F1A4-4A34-9A87-04081F850619 @default.
- Q65346681 P17 Q65346681-3BAEF603-FC86-44E9-B3BD-E56C80B37BC5 @default.
- Q65346681 P17 Q65346681-3BB37144-6063-426E-AE06-8EB0CBB69280 @default.
- Q65346681 P17 Q65346681-9FFBBC73-2750-4D0C-A7A2-F8ADA0150E55 @default.
- Q65346681 P17 Q65346681-B44962E9-DA50-402B-BBCC-7675DE27C6FA @default.
- Q65346681 P2899 Q65346681-994F06B7-B3C9-4B51-9232-FA91C4D89556 @default.
- Q65346681 P3098 Q65346681-7CF8A0A4-C8BA-4389-AC30-F94941314A75 @default.
- Q65346681 P31 Q65346681-092E3E40-3D31-400C-9D71-FA2675BC77B9 @default.
- Q65346681 P4135 Q65346681-DDBDC614-6F94-47BA-B334-B4F0B149EF98 @default.
- Q65346681 P4844 Q65346681-F7CE8D72-659C-4AB3-B495-7EE427A36865 @default.
- Q65346681 P580 Q65346681-FD44A2BB-74F3-4EE6-8C96-613FA125D57D @default.
- Q65346681 P582 Q65346681-DC926AB3-40B3-4188-8696-259BC958655E @default.
- Q65346681 P6099 Q65346681-10DFD563-B2E4-4429-BE0B-4D4DE62B47C6 @default.
- Q65346681 P8363 Q65346681-EDD30DD8-812B-4C21-B9EC-B5FFD495F158 @default.
- Q65346681 P1050 Q467635 @default.
- Q65346681 P1132 "+74" @default.
- Q65346681 P1476 "A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma" @default.
- Q65346681 P17 Q142 @default.
- Q65346681 P17 Q183 @default.
- Q65346681 P17 Q29 @default.
- Q65346681 P17 Q30 @default.
- Q65346681 P2899 "+18" @default.
- Q65346681 P3098 "NCT02462525" @default.
- Q65346681 P31 Q30612 @default.
- Q65346681 P4135 "+99" @default.
- Q65346681 P4844 Q408524 @default.
- Q65346681 P580 "2015-05-06T00:00:00Z" @default.
- Q65346681 P582 "2017-12-06T00:00:00Z" @default.
- Q65346681 P6099 Q5452194 @default.
- Q65346681 P8363 Q78089383 @default.